Analyst Alerts: Sina, Groupon, Boston Scientific April 2nd

Sina Corp. (NASDAQ:SINA): Piper Jaffray views Sina and Tencent disabling the commenting feature of their Weibo platforms amid political speculation as a negative headline for Sina, but does not view the temporary shut down as a signal of something potentially worse to come. Piper adds that users are still able to comment by posting new messages that reference the messages of other users.

Groupon Inc (NASDAQ:GRPN): William Blair does not expect Groupon to have another accounting reserve restatement and thinks the company’s business will quickly move beyond the non-cash restatement announced late Friday. The firm believes Groupon has improved its reserve forecasting techniques and keeps an Outperform rating on the stock.

Boston Scientific Corporation (NYSE:BSX): Credit Suisse’s S-ICD survey indicates a better than expected opportunity for Boston Scientific recently acquired Cameron Heart S-ICD. Respondents indicated a higher than expected ICD volumes which would add 2-3% more to 2015 Boston Scientific sales. Shares are Outperform rated with a $7 price target.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at